Consulting Services
For Investors
Products
Case Studies
Insights
BioPharma and Tech News

Contact Us

Search

guselkumab

Immunology

Immunology Video Recap—January 14, 2026

This Immunology video highlights major regulatory approvals, late-stage…

Immunology

Immunology Today—November 19, 2025

This weekly Immunology newsletter features late-phase efficacy readouts,…

Immunology

Immunology Today: Zenas MS Deal, J&J FDA Approvals (Oct 8–15, 2025)

This week’s immunology news update includes Zenas BioPharma securing global…

Categories

Obesity News
Endocrinology News
Our Insights
Immunology News
Case studies
Hematology News
BioPharma and Tech News
Oncology News
BioPharma Strategy, CI and AI Guides
Lucid Diligence Brief
Conference Social Media Reports
Venture Capital Trends
AI in Healthcare and Digital Health
Conference Previews
Cell and Gene Therapy News
Healthcare and Pharma Trends
Rare Disease News
Health Mobile Apps Reports
Neuroscience News
Women's Health News
Public Health News
Respiratory News
Cardiovascular News
Vaccine news

Recent Posts

Endocrinology Video Recap—February 24, 2026
Endocrinology Today—February 24, 2026
Obesity Today—February 24, 2026
Lucid Diligence Brief: Angelini Pharma collaboration with Quiver Bioscience on genetic epilepsies
Hematology Video Recap—February 23, 2026

Tags

adenoid cystic carcinoma AMA CPT 2026 Anti-IL-18 B-cell therapy BARDA Blood Cancer United BRIUMVI BRT-DA01 Cook MyoSite Crinetics CRISPR-GPT CRISPRa Deciphera DisaggproT Edwards Lifesciences ER+ HER2– MBC ESR1 mutation FG-3180 Fibrodysplasia Ossificans Progressiva FXI siRNA Gates Foundation HealthTree Foundation Hemi-valve HKUMed IDH2 Insulin Initiation Intermountain Health IVF Leukemia ML models Lykos Therapeutics MET-233i MIRACLE trial mResvia National MS Society Nubeqa NYU Langone Health Pirtobrutinib PUL 2.0 RSL Collective SPMS TG4050 THRβ treprostinil upadacitinib uPAR

Archives

Archives

LucidQuest Ventures

Accelerate Your Success

LATEST NEWS

Endocrinology Video Recap—February 24, 2026
Endocrinology Today—February 24, 2026
Obesity Today—February 24, 2026
Lucid Diligence Brief: Angelini Pharma collaboration with Quiver Bioscience on genetic epilepsies
Hematology Video Recap—February 23, 2026

TAGS

adenoid cystic carcinoma AMA CPT 2026 Anti-IL-18 B-cell therapy BARDA Blood Cancer United BRIUMVI BRT-DA01 Cook MyoSite Crinetics CRISPR-GPT CRISPRa Deciphera DisaggproT Edwards Lifesciences ER+ HER2– MBC ESR1 mutation FG-3180 Fibrodysplasia Ossificans Progressiva FXI siRNA Gates Foundation HealthTree Foundation Hemi-valve HKUMed IDH2 Insulin Initiation Intermountain Health IVF Leukemia ML models Lykos Therapeutics MET-233i MIRACLE trial mResvia National MS Society Nubeqa NYU Langone Health Pirtobrutinib PUL 2.0 RSL Collective SPMS TG4050 THRβ treprostinil upadacitinib uPAR

Consulting Services
For Investors
Products
Case Studies
Insights
BioPharma and Tech News

© 2026 LucidQuest Ventures. All rights reserved

We use cookies from third party services to offer you a better experience. Read about how we use cookies and how you can control them by clicking "Privacy Preferences".

Privacy Preference Center

Privacy Preferences

When you visit any website, it may store or retrieve information on your browser in the form of cookies. Since we respect your right to privacy, you can choose not to permit data collection from certain types of services. However, not allowing these services may impact your experience ans we are able to offer you.

Privacy Policy

Required

You read and agreed to our Privacy Policy

Tracking

We use third-party cookies that help us analyze and understand how you use this website. These cookies do not store any personal information.

Privacy Policy